News

Community Health heads into Q2 earnings with mixed operating trends as stronger occupancy meets lower admissions and a smaller hospital portfolio.

NOC heads into Q2 earnings backed by a strong defense backlog, but investors will watch Sentinel program updates for margin impact.

Big Tech's earnings are coming fast, and it'll be all about AI spending.

J.B. Hunt's Q2 earnings beat estimates as intermodal growth, pricing and cost discipline lift revenues, operating income and margins.

Helios has had an impressive run over the past six months as its shares have beaten the S&P 500 by 16.8%. The stock now trades at $80.44, marking a 25.5% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Trex has been treading water for the past six months, recording a small return of 0.6% while holding steady at $44.00. The stock also fell short of the S&P 500’s 8.7% gain during that period.

The banking giant just showed off its profit engine, but now it has to prove this new power is permanent.

Abbott Laboratories (NYSE:ABT) shares rose nearly 11% on Thursday after the healthcare company reported second quarter 2026 results that topped Wall Street expectations and raised its full-year adjusted earnings guidance. The company posted adjusted diluted earnings per share of $1.31 for the...

UNH beats Q2 earnings estimates on lower medical costs and stronger Optum Insight, then raises its 2026 EPS and cash flow outlook.

After a very strong 5 year run, Applied Materials now sits in a valuation grey area where the share price strength contrasts with a relatively low overall value score and an earnings multiple picture that looks closer to about right than clearly cheap. Applied Materials has returned about 3.4x over 5 years, which means new buyers are being asked to pay up compared with where the stock traded earlier in the AI build out. Long term AI related equipment demand and recent multi year partnerships...

Q2 earnings are off to a strong start. Tech, Energy, Materials, Finance and Aerospace ETFs could shine as profit growth broadens across sectors.

Monolithic (MPWR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Microchip Tech (MCHP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Blackstone Inc. (BX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

General Motors (GM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

United Airlines (NASDAQ:UAL) executives said the carrier’s second-quarter 2026 results showed strong demand, improving pricing and continued operational gains, even as a sharp increase in fuel prices pressured earnings and led the company to update its guidance approach. Chief Executive Officer Sco

Netflix stock has struggled this year.

GE Aerospace (General Electric Co (NYSE:GE)) reported better-than-expected second-quarter 2026 results, but shares fell about 4% as investors weighed the company’s strong performance against already elevated expectations and signs that order growth is beginning to moderate. The aerospace...

ABT tops Q2 earnings and revenue estimates and lifts 2026 EPS guidance, while Medical Devices and Cancer Diagnostics fuel growth despite Nutrition weakness.

DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.

Netflix Inc (NASDAQ:NFLX, XETRA:NFC) reports second quarter earnings tonight, and two major brokerages are sticking with their bullish calls even as the stock has struggled this year. Shares were little changed Thursday at $73.50, but that stability masks a rough 2026 for Netflix investors:...

The S&P 500 and Nasdaq Composite were down in late-morning trading Thursday, while the Dow Jones Ind

AMC heads into Q2 earnings with a positive Earnings ESP, stronger box-office momentum and recent debt refinancing improving financial flexibility.

Fred Alger Management, an investment management company, released its “Alger Capital Appreciation Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. US equities strongly rebounded in the second quarter, with the S&P 500 Index rising 15.2%. Easing geopolitical tensions and technological advancements fueled market optimism, propelling the Information Technology and […]

UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares climbed about 5% in post-market trading after the healthcare company reported second quarter results that beat Wall Street expectations and raised its full-year adjusted earnings outlook. For the quarter ended June 30, UnitedHealth reported...

GE beats Q2 2026 estimates as commercial services, strong orders and cash flow fuel growth, prompting higher full-year guidance.

Mosaic (MOS) is back in focus after management scheduled its second quarter 2026 earnings release for August 4, followed by an investor conference call on August 5 to discuss the results. See our latest analysis for Mosaic. Mosaic’s recent 7 day share price return of 11.57% comes after a weaker patch, with the 90 day share price return down 6.83% and the 1 year total shareholder return down 32.86%. Short term momentum is improving while longer term performance remains under pressure as the...

Centene’s updated price target framework now reflects a fair value revision from US$61.83 to US$63.78, a modest uplift that has caught investor attention. Research commentary links this shift to a more constructive view on Centene’s earnings power, supported by trends in exchanges, Medicare Advantage, and early signs of Medicaid margin recovery, while still pointing out execution and policy risks. As you read on, you will see how this evolving analyst narrative may matter for your own view of...

The stock is still 25% off all-time highs.